 |
 |
 |
|
 |
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
Comment Period Clarification: Docket No. 2007N-0356, OC 2007286. Behind the Counter Availability of Certain Drugs; Public Meeting; Comment Period Clarification. Pages 66180-66181 [FR Doc. E7-23026 ] [TXT] [PDF] [PRE-PUB]
Comments due December 17, 2007
The FDA is interested in obtaining public comment as it explores the public health benefit of certain drugs being available without a prescription but only after intervention by a pharmacist. The purpose of the meeting is to solicit information and views from interested persons on specific issues associated with BTC availability, including the impact on patient access to safe and effective drug products.
Send Comments:
Division of Dockets Management (HFA-305)
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, Maryland 20852
Location: National Transportation and Safety Board (NTSB) Boardroom and Conference Center, 429 L’Enfant Plaza, SW, Washington, DC 20594. Metro: L’Enfant Plaza Station on the Green, Yellow, Blue, and Orange Lines.
http://www.ntsb.gov/Events/newlocation.htm
For all meeting materials or any other information please contact Erik Mettler at erik.mettler@fda.hhs.gov or 301-827-3360.